Abstract:ABSTRACT Drug addiction can seriously damage human physical and mental health, while detoxification is a long and difficult process. Although studies have reported changes in the oral microbiome of methamphetamine (METH) users, the role that the microbiome plays in the process of drug addiction is still unknown. This study aims to explore the function of the microbiome based on analysis of the variations in the oral microbiome and metabolome of METH users. We performed the 16S rRNA sequencing analysis based on the oral saliva samples collected from 278 METH users and 105 healthy controls (CTL). In addition, the untargeted metabolomic profiling was conducted based on 220 samples. Compared to the CTL group, alpha diversity was reduced in the group of METH users and the relative abundances of Peptostreptococcus and Gemella were significantly increased, while the relative abundances of Campylobacter and Aggregatibacter were significantly decreased. Variations were also detected in oral metabolic pathways, including enhanced tryptophan metabolism, lysine biosynthesis, purine metabolism, and steroid biosynthesis. Conversely, the metabolic pathways of porphyrin metabolism, glutathione metabolism, and pentose phosphate were significantly reduced. It was speculated that four key microbial taxa, i.e., Peptostreptococcus , Gemella , Campylobacter , and Aggregatibacter , could be involved in the toxicity and addiction mechanisms of METH by affecting the above metabolic pathways. It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders was gradually increased. Our study provides novel insights into exploring the toxic damage and addiction mechanisms underlying the METH addiction. IMPORTANCE It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders gradually increased. The prediction models based on oral microbiome and metabolome could effectively predict the methamphetamine (METH) smoking. Our study provides novel insights into the exploration of the molecular mechanisms regulating the toxic damage and addiction of METH as well as new ideas for early prevention and treatment strategies of METH addiction.

Exploring the role and mechanism of gut microbiota in methamphetamine addiction using antibiotic treatment followed by fecal microbiota transplantation

The role of the microbiota–gut–brain axis in methamphetamine-induced neurotoxicity: Disruption of microbial composition and short-chain fatty acid metabolism

Alterations in Gut Microbiota Affect Behavioral and Inflammatory Responses to Methamphetamine in Mice

Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference

Differential Perturbations of Gut Microbial Profiles and Co-Occurrence Networks among Phases of Methamphetamine-Induced Conditioned Place Preference

Gut Dysbiosis Associated with the Rats' Responses in Methamphetamine‐induced Conditioned Place Preference

Associations between impulsivity and fecal microbiota in individuals abstaining from methamphetamine

Gut-derived bacterial LPS attenuates incubation of methamphetamine craving via modulating microglia

Alterations in the oral microbiome and metabolome of methamphetamine addicts

Characterization of Gut Microbiota in Rats and Rhesus Monkeys After Methamphetamine Self-administration

Effect of Aerobic Exercise on Intestinal Microbiota with Amino Acids and Short-Chain Fatty Acids in Methamphetamine-Induced Mice

Impact of Altered Gut Microbiota on Ketamine-Induced Conditioned Place Preference in Mice

Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder

Gut microbiota contribute to Methamphetamine-induced cardiotoxicity in mouse model

The gut microbiota contributes to methamphetamine-induced reproductive toxicity in male mice

Gut Microbiota Taxon-Dependent Transformation of Microglial M1/M2 Phenotypes Underlying Mechanisms of Spatial Learning and Memory Impairment after Chronic Methamphetamine Exposure

Gut Microbiota Mediates Methamphetamine-Induced Hepatic Inflammation Via the Impairment of Bile Acid Homeostasis.

Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner

Lycium barbarum polysaccharide mitigated methamphetamine addiction and altered methamphetamine‐induced gut microbiota dysbiosis

Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice

Variations in the oral microbiome and metabolome of methamphetamine users